All Research on Biotech

Insight

Case Studies
Case Studies

Alexion Pharmaceuticals, Inc.: Focus on ultra-rare diseases as a revenue and profit driver

In 2007, Alexion gained marketing approval for Soliris, which has since become the world’s single most expensive orphan drug. This case study analyzes Alexion's success with Soliris, potential challenges, and how it is combatting these going forward.

Published By MarketLine
$495
Buy
Report
Report

The Orphan Drug Market Outlook to 2017

This report provides an analysis of the orphan drug market. It comprises brands that have gained US FDA orphan drug approval, as well as Phase III pipeline candidates that have gained an orphan drug designation from the FDA.

Published By Datamonitor
$2800
Buy
Report
Report

Hemophilia Pipeline Overview – Once-a-week prophylaxis may soon become a reality

Datamonitor provides an overview of and profiles key hemophilia A and B pipeline products launching in the near future in the US and five major EU markets (France, Germany, Italy, Spain, and the UK).

Published By Datamonitor
$2800
Buy

View all Insight >>

Market Data

Databook
Databook

Company Financials: Sunesis Pharmaceuticals, Inc.

In-depth Company Financials with Key Ratios, and Revenue details by segments and geographies for the last five years download the attached datapack (.xls file)

Published By Datamonitor
$75
Buy

Profiles

Company Profile
Company Profile

Sanofi SA

Sanofi (or 'the group') is a France-based international pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products. It offers biopharmaceuticals, human vaccines and animal and consumer health products. The group operates in more than 100 countries. It is headquartered in Paris, France, and employed 112,128 people as of December 31, 2013.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

Merck & Co., Inc.

Merck & Co. (or 'the company'), known as Merck Sharp & Dohme (MSD) outside the US and Canada, is one of the leading healthcare companies in the world. The company is engaged in the research, development, manufacture and marketing of prescription pharmaceuticals, vaccines, biologic therapies, and consumer care and animal health products. It is headquartered in Whitehouse Station, New Jersey, and employed about 76,000 people as of December 31, 2013.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

Amgen, Inc.

Amgen (or 'the company') is a leading biotechnology company engaged in the discovery, development, manufacture, and marketing of innovative human therapeutics. The company mainly focuses in the areas of cancer, kidney disease, rheumatoid arthritis and other serious illnesses. It primarily operates in the US where it is headquartered in Thousand Oaks, California. Amgen employed about 20,000 people as of December 31, 2013.

Published By MarketLine
$175
Buy

View all Profiles >>

No help is available.